[Problem] To do not have a
gene introduction method that has high
gene introduction efficiency and high specificity to
skin,
subcutaneous tissue,
skin ulcer surfaces and constituent cells thereof. More generally, it is difficult to achieve high
gene introduction efficiency in gene introduction into a
living body. The
skin appendages are difficult to regenerate in
form and function; when the tip tissues (
upper arms, forearms, hands, fingers, thighs, shanks, feet, toes) of the upper limbs and the lower limbs are lost, regeneration is difficult. The solution is that: a novel AAV (AAV is an abbreviation of an adeno-associated
virus)
capsid having high gene introduction efficiency and high specificity to cells of skin / subcutaneous tissues and
skin ulcer surfaces, and a novel AAV
capsid having high gene introduction efficiency and high specificity to epidermal tissues and cells constituting the epidermal tissues, namely keratinocytes; disclosed is a novel tissue-specific
promoter having high
gene expression and high specificity against epidermal tissue and keratinocytes constituting the epidermal tissue, and a pharmaceutical product having improved gene introduction efficiency by using a
steroid together with gene introduction in a
living body. The present invention relates to a pharmaceutical product for inducing regeneration, regeneration and function improvement of a
skin appendage by introducing a gene into a
living body in order to achieve sufficient
skin appendage functions, a research and development platform for developing a regeneration method for
peripheral tissues and defective tissues of upper and lower limbs, and a pharmaceutical product for regeneration, and more particularly, to a pharmaceutical product for regeneration for inducing regeneration, regeneration and function improvement of the
skin appendage by introducing a gene into the living body in a state where the function of the skin
appendage is reduced. Thus, a method for solving the above problem is provided.